The FluoroSpot market is no longer a niche segment of the immunoassay industry; it has become a cornerstone of precision medicine. With a projected valuation exceeding USD 1 billion by 2032, the shift toward automation and the necessity for polyfunctional T-cell analysis ensure that this t